A study published in Nature has demonstrated how artificial intelligence (AI) research can drive and accelerate new scientific discoveries.
Alphabet subsidiary DeepMind has created a dedicated, interdisciplinary team to explore using AI to predict the 3D structure of a protein based solely on its genetic sequence.
Its system, AlphaFold, builds on prior research using large genomic datasets to...
German pharma giant Bayer and British biotech firm Exscientia have announced a three-year partnership focused on the use of Artificial Intelligence in cardiovascular and oncology drug discovery.
The collaboration will initially see the companies work on three early-stage research projects, combining Bayer’s data and drug discovery capabilities and Exscientia’s Centaur Chemist platform.
According...
Google’s artificial intelligence proved more accurate in identifying breast cancer from mammograms than doctors, according to a study published in Nature yesterday.
The initial results of Google’s AI for breast cancer screening, found that the system was able to reduce the number of both false positives and false negatives in breast cancer detection. The study was born out of a collaboration...
OM1, a Boston-based artificial intelligence platform for clinical real-world evidence, has raised $50 million in Series C funding. Scale Venture Partners led the round consisting of support from prior backers General Catalyst, Polaris Partners and 7wire Ventures.
WHAT THEY DO
OM1’s cloud platform employs AI machine learning organize and analyze large datasets for real-world measures of clinical...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
